Literature DB >> 32342809

A Comprehensive Review of Monoamine Oxidase-A Inhibitors in their Syntheses and Potencies.

Nisha A Rehuman1, Bijo Mathew2, Rakesh K Jat1, Orazio Nicolotti3, Hoon Kim4.   

Abstract

BACKGROUND: Monoamine oxidases (MAOs) play a crucial role during the development of various neurodegenerative disorders. There are two MAO isozymes, MAO-A and MAO-B. MAO-A is a flavoenzyme, which binds to the outer mitochondrial membrane and catalyzes the oxidative transformations of neurotransmitters like serotonin, norepinephrine, and dopamine.
MATERIALS AND METHODS: Focus on synthetic studies has culminated in the preparation of many MAOA inhibitors, and advancements in combinatorial and parallel synthesis have accelerated the developments of synthetic schemes. Here, we provided an overview of the synthetic protocols employed to prepare different classes of MAO-A inhibitors. We classified these inhibitors according to their molecular scaffolds and the synthetic methods used.
RESULTS: Various synthetic and natural derivatives from a different class of MAO-A inhibitors were reported.
CONCLUSION: The review provides a valuable tool for the development of a new class of various selective MAO-A inhibitors for the treatment of depression and other anxiety disorders. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  MAO-A; MAO-B; inhibitors; molecular scaffolds; neurodegenerative disorders; neurotransmitters

Mesh:

Substances:

Year:  2020        PMID: 32342809     DOI: 10.2174/1386207323666200428091306

Source DB:  PubMed          Journal:  Comb Chem High Throughput Screen        ISSN: 1386-2073            Impact factor:   1.339


  3 in total

1.  Morpholine-based chalcones as dual-acting monoamine oxidase-B and acetylcholinesterase inhibitors: synthesis and biochemical investigations.

Authors:  Rani Sasidharan; Bo Hyun Eom; Jeong Hyun Heo; Jong Eun Park; Mohamed A Abdelgawad; Arafa Musa; Nicola Gambacorta; Orazio Nicolotti; Sreedharannair Leelabaiamma Manju; Bijo Mathew; Hoon Kim
Journal:  J Enzyme Inhib Med Chem       Date:  2021-12       Impact factor: 5.051

2.  Development of a Novel Class of Pyridazinone Derivatives as Selective MAO-B Inhibitors.

Authors:  Mehmet Abdullah Alagöz; Jong Min Oh; Yaren Nur Zenni; Zeynep Özdemir; Mohamed A Abdelgawad; Ibrahim A Naguib; Mohammed M Ghoneim; Nicola Gambacorta; Orazio Nicolotti; Hoon Kim; Bijo Mathew
Journal:  Molecules       Date:  2022-06-13       Impact factor: 4.927

3.  A Combined Network Pharmacology and Molecular Docking Approach to Investigate Candidate Active Components and Multitarget Mechanisms of Hemerocallis Flowers on Antidepressant Effect.

Authors:  Tiancheng Ma; Yu Sun; Chang Jiang; Weilin Xiong; Tingxu Yan; Bo Wu; Ying Jia
Journal:  Evid Based Complement Alternat Med       Date:  2021-06-30       Impact factor: 2.629

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.